← Leaderboards
Mary Sano
Columbia University Health Sciences
$40,764,266
Attributed
$43,612,367
Total exposure
29
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$98,450,558 · 30
VA$0 · 1
By mechanism
P50$40,137,876 · 8
P30$25,945,602 · 4
R01$19,820,488 · 3
U01$6,771,586 · 4
M01$2,678,424 · 9
R24$1,857,195 · 1
Top collaborators
- Michal Schnaider Beeri6 shared
- Mark G Baxter3 shared
- Joshua Samuel Mincer3 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Mathew S Maurer$11,052,259
- Marco R Di Tullio$6,840,545
- Karen S Marder$15,291,810
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposDementiaClinical TrialsS DiseaseClinical ResearchCommunitiesResearch PersonnelResourcesEvaluationHuman SubjectSuccessCohortDiagnosisProgramsImpaired CognitionOutreachEnsureTrainingAlzheimer'S DiseaseElderlyFundingParticipantSamplingHuman Therapy Evaluation
Grant awards (147)
Mount Sinai Alzheimer's Disease Research Center$4,736,863
P30 · FY2025 · AG · contact PI
Core A - Admin Core$1,236,654
P30 · FY2025 · AG · contact PI
Alzheimer's Disease Research Center$3,034,446
P30 · FY2024 · AG · contact PI
Administrative Core$562,013
P30 · FY2024 · AG · contact PI
Alzheimer's Disease Research Center$3,458,408
P30 · FY2023 · AG · contact PI
Administrative Core$655,603
P30 · FY2023 · AG · contact PI
Alzheimer's Disease Research Center$3,042,031
P30 · FY2022 · AG · contact PI
Administrative Core$629,582
P30 · FY2022 · AG · contact PI
Recruitment Accelerator for Diversity in Aging Research, Cognitive Loss and Dementia (RADAR-CLD)$574,818
R24 · FY2022 · AG · contact PI
Mount Sinai Alzheimer's Disease Research Center$422,500
P30 · FY2022 · AG · contact PI
Alzheimer's Disease Research Center$3,041,622
P30 · FY2021 · AG · contact PI
Hyperbaric oxygen therapy for cognition in diabetic elderly at high dementia risk$796,424
R01 · FY2021 · AG · contact PI
Administrative Core$787,699
P30 · FY2021 · AG · contact PI
Recruitment Accelerator for Diversity in Aging Research, Cognitive Loss and Dementia (RADAR-CLD)$584,605
R24 · FY2021 · AG · contact PI
Alzheimer's Disease Research Center$3,029,312
P30 · FY2020 · AG · contact PI
Hyperbaric oxygen therapy for cognition in diabetic elderly at high dementia risk$796,424
R01 · FY2020 · AG
Recruitment Accelerator for Diversity in Aging Research, Cognitive Loss and Dementia (RADAR-CLD)$697,772
R24 · FY2020 · AG · contact PI
Administrative Core$570,749
P30 · FY2020 · AG · contact PI
Alzheimer's Disease Research Center$423,750
P30 · FY2020 · AG · contact PI
Alzheimer's Disease Research Center Supplement for VA Collaboration$314,370
P30 · FY2020 · AG · contact PI
Alzheimer's Disease Research Center$2,212,107
P50 · FY2019 · AG · contact PI
Core A - Administrative$334,672
P50 · FY2019 · AG · contact PI
Hyperbaric oxygen therapy for cognition in diabetic elderly at high dementia risk$219,517
R01 · FY2019 · AG
Alzheimer's Disease Research Center$2,208,597
P50 · FY2018 · AG · contact PI
Hyperbaric oxygen therapy for cognition in diabetic elderly at high dementia risk$611,657
R01 · FY2018 · AG
Trajectory of Recovery in the Elderly$483,705
R01 · FY2018 · AG
Core A - Administrative$333,949
P50 · FY2018 · AG · contact PI
Alzheimer's Disease Research Center$1,831,094
P50 · FY2017 · AG · contact PI
Hyperbaric oxygen therapy for cognition in diabetic elderly at high dementia risk$611,657
R01 · FY2017 · AG
Trajectory of Recovery in the Elderly$497,271
R01 · FY2017 · AG
Core A - Administrative$266,314
P50 · FY2017 · AG · contact PI
Administrative Supplement: Career Development in the Neuropathology of AD$251,341
P50 · FY2017 · AG · contact PI
RECRUITMENT CORE$231,811
U19 · FY2017 · AG · contact PI
Core F: Genetic and Genomics$215,840
P50 · FY2017 · AG · contact PI
Alzheimer's Disease Research Center$1,831,386
P50 · FY2016 · AG · contact PI
Hyperbaric oxygen therapy for cognition in diabetic elderly at high dementia risk$663,782
R01 · FY2016 · AG
Trajectory of Recovery in the Elderly$516,580
R01 · FY2016 · AG
Core A - Administrative$267,793
P50 · FY2016 · AG · contact PI
RECRUITMENT CORE$251,698
U19 · FY2016 · AG · contact PI
Alzheimer's Disease Research Center$1,843,698
P50 · FY2015 · AG · contact PI
Core A - Administrative$263,806
P50 · FY2015 · AG · contact PI
RECRUITMENT CORE$244,148
U19 · FY2015 · AG · contact PI
Administrative Supplement: Career Development in the Neuropathology of AD$200,000
P50 · FY2015 · AG · contact PI
Markers of transition to Alzheimer disease in veterans with MCI$0
I01 · FY2015 · VA · contact PI
Alzheimer's Disease Research Center$1,719,660
P50 · FY2014 · AG · contact PI
CLINICAL CORE$254,373
P50 · FY2014 · AG · contact PI
RECRUITMENT CORE$251,697
U19 · FY2014 · AG · contact PI
ADMINISTRATIVE CORE$249,061
P50 · FY2014 · AG · contact PI
Markers of transition to Alzheimer disease in veterans with MCI$0
I01 · FY2014 · VA · contact PI
Alzheimer's Disease Research Center$1,613,910
P50 · FY2013 · AG · contact PI
RECRUITMENT CORE$260,033
U19 · FY2013 · AG · contact PI
CLINICAL CORE$259,413
P50 · FY2013 · AG · contact PI
ADMINISTRATIVE CORE$258,823
P50 · FY2013 · AG · contact PI
Markers of transition to Alzheimer disease in veterans with MCI$0
I01 · FY2013 · VA · contact PI
Alzheimer's Disease Research Center$1,736,563
P50 · FY2012 · AG · contact PI
ADMINISTRATIVE CORE$277,997
P50 · FY2012 · AG · contact PI
CLINICAL CORE$273,739
P50 · FY2012 · AG · contact PI
Markers of transition to Alzheimer disease in veterans with MCI$0
I01 · FY2012 · VA · contact PI
Alzheimer's Disease Research Center$1,743,823
P50 · FY2011 · AG · contact PI
HOME BASED ASSESSMENT OF ELDERLY AT RISK FOR COGNITIVE DECLINE, MCI AND AD$566,116
U01 · FY2011 · AG · contact PI
ADMINISTRATIVE CORE$300,076
P50 · FY2011 · AG · contact PI
CLINICAL CORE$289,757
P50 · FY2011 · AG · contact PI
RECRUITMENT CORE (RC)$133,732
U01 · FY2011 · AG · contact PI
Alzheimer's Disease Research Center$1,781,184
P50 · FY2010 · AG · contact PI
HOME BASED ASSESSMENT OF ELDERLY AT RISK FOR COGNITIVE DECLINE, MCI AND AD$974,570
U01 · FY2010 · AG · contact PI
ADMINISTRATIVE CORE$271,155
P50 · FY2010 · AG · contact PI
CLINICAL CORE$260,528
P50 · FY2010 · AG · contact PI
RECRUITMENT CORE (RC)$136,104
U01 · FY2010 · AG · contact PI
Alzheimer's Disease Research Center$1,739,396
P50 · FY2009 · AG · contact PI
HOME BASED ASSESSMENT OF ELDERLY AT RISK FOR COGNITIVE DECLINE, MCI AND AD$1,178,119
U01 · FY2009 · AG · contact PI
CORE--CLINICAL CORE$450,128
P50 · FY2009 · AG · contact PI
RECRUITMENT CORE (RC)$131,876
U01 · FY2009 · AG · contact PI
CORE--EDUCATION AND INFORMATION TRANSFER CORE$100,747
P50 · FY2009 · AG · contact PI
Alzheimer's Disease Research Center$1,694,021
P50 · FY2008 · AG · contact PI
HOME BASED ASSESSMENT OF ELDERLY AT RISK FOR COGNITIVE DECLINE, MCI AND AD$946,004
U01 · FY2008 · AG · contact PI
CORE--CLINICAL CORE$438,092
P50 · FY2008 · AG · contact PI
RECRUITMENT CORE (RC)$108,864
U01 · FY2008 · AG · contact PI
CORE--EDUCATION AND INFORMATION TRANSFER CORE$98,052
P50 · FY2008 · AG · contact PI
Alzheimer's Disease Prevention Trial with Estrogens$1,690,981
R01 · FY2007 · AG · contact PI
Alzheimer's Disease Research Center$1,683,632
P50 · FY2007 · AG · contact PI
HOME BASED ASSESSMENT OF ELDERLY AT RISK FOR COGNITIVE DECLINE, MCI AND AD$964,292
U01 · FY2007 · AG · contact PI
CORE--CLINICAL CORE$435,109
P50 · FY2007 · AG · contact PI
RECRUITMENT CORE (RC)$105,694
U01 · FY2007 · AG · contact PI
CORE--EDUCATION AND INFORMATION TRANSFER CORE$97,374
P50 · FY2007 · AG · contact PI
Alzheimer's Disease Prevention Trial with Estrogens$1,737,835
R01 · FY2006 · AG · contact PI
Alzheimer's Disease Research Center$1,688,644
P50 · FY2006 · AG · contact PI
HOME BASED ASSESSMENT OF ELDERLY AT RISK FOR COGNITIVE DECLINE, MCI AND AD$1,195,196
U01 · FY2006 · AG · contact PI
CORE--CLINICAL CORE$237,061
P50 · FY2006 · AG · contact PI
RECRUITMENT CORE (RC)$102,615
U01 · FY2006 · AG · contact PI
CORE--EDUCATION AND INFORMATION TRANSFER CORE$53,053
P50 · FY2006 · AG · contact PI
Alzheimer's Disease Prevention Trial with Estrogens$1,734,531
R01 · FY2005 · AG
Alzheimer's Disease Research Center$1,643,177
P50 · FY2005 · AG
CORE--CLINICAL CORE$230,156
P50 · FY2005 · AG
ADMINISTRATIVE CORE$178,856
P50 · FY2005 · AG
CORE--EDUCATION AND INFORMATION TRANSFER CORE$51,508
P50 · FY2005 · AG
Alzheimer's Disease Research Center$38,421
P50 · FY2005 · AG
Alzheimer's Disease Prevention Trial with Estrogens$1,684,857
R01 · FY2004 · AG
ALZHEIMERS DISEASE RESEARCH CENTER$669,993
P50 · FY2004 · AG
ALZHEIMERS DISEASE RESEARCH CENTER$169,500
P50 · FY2004 · AG
ALZHEIMERS DISEASE RESEARCH CENTER$2,000
P50 · FY2004 · AG
ALZHEIMERS DISEASE RESEARCH CENTER$2,288,492
P50 · FY2003 · AG
Alzheimer's Disease Prevention Trial with Estrogens$1,676,632
R01 · FY2003 · AG
ALZHEIMERS DISEASE RESEARCH CENTER$169,500
P50 · FY2003 · AG
ALZHEIMERS DISEASE RESEARCH CENTER$2,358,910
P50 · FY2002 · AG
ALZHEIMERS DISEASE PREVENTION TRIAL WITH ESTROGENS$1,777,049
R01 · FY2002 · AG
MULTICENTER PLACEBO CONTROLLED TRIAL OF MELATONIN FOR SLEEP DISTURBAN$192,910
M01 · FY2002 · RR
TRIAL OF 120,240,360 MG OF IDEBENONE IN PATIENTS WITH ALZHEIMER'S DISEASE$192,910
M01 · FY2002 · RR
DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF DEPRENYL IN COMMUNITY ELDERLY$192,910
M01 · FY2002 · RR
EXELON IN MILD TO SEVERE PROBABLE ALZHEIMER'S DISEASE IN COMMUNITY SETTING$192,910
M01 · FY2002 · RR
VITAMIN E AND ARICEPT TO DELAY ALZHEIMER'S DISEASE$192,910
M01 · FY2002 · RR
ALZHEIMER'S DISEASE PREVENTION TRIAL WITH ESTROGEN$192,910
M01 · FY2002 · RR
ALZHEIMERS DISEASE PREVENTION TRIAL WITH ESTROGENS$67,039
R01 · FY2002 · AG
TRIAL OF LOVASTATIN TO SLOW RATE OF PROGRESSION OF AD$0
U01 · FY2002 · AG
TRIAL OF LOVASTATIN TO SLOW RATE OF PROGRESSION OF AD$0
U01 · FY2002 · AG
ALZHEIMERS DISEASE PREVENTION TRIAL WITH ESTROGENS$2,175,701
R01 · FY2001 · AG
ALZHEIMER'S DISEASE PREVENTION TRIAL WITH ESTROGEN$192,910
M01 · FY2001 · RR
MULTICENTER PLACEBO CONTROLLED TRIAL OF MELATONIN FOR SLEEP DISTURBAN$192,910
M01 · FY2001 · RR
VITAMIN E AND ARICEPT TO DELAY ALZHEIMER'S DISEASE$192,910
M01 · FY2001 · RR
TRIAL OF 120,240,360 MG OF IDEBENONE IN PATIENTS WITH ALZHEIMER'S DISEASE$192,910
M01 · FY2001 · RR
DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF DEPRENYL IN COMMUNITY ELDERLY$192,910
M01 · FY2001 · RR
EXELON IN MILD TO SEVERE PROBABLE ALZHEIMER'S DISEASE IN COMMUNITY SETTING$192,910
M01 · FY2001 · RR
TRIAL OF 120,240,360 MG OF IDEBENONE IN PATIENTS WITH ALZHEIMER'S DISEASE$0
M01 · FY2001 · RR
ALZHEIMER'S DISEASE PREVENTION TRIAL WITH ESTROGEN$0
M01 · FY2001 · RR
CORE--MINORITY RECRUITMENT$0
U01 · FY2001 · AG
TRIAL OF LOVASTATIN TO SLOW RATE OF PROGRESSION OF AD$0
U01 · FY2001 · AG
VITAMIN E AND ARICEPT TO DELAY ALZHEIMER'S DISEASE$0
M01 · FY2001 · RR
DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF DEPRENYL IN COMMUNITY ELDERLY$0
M01 · FY2001 · RR
MULTICENTER PLACEBO CONTROLLED TRIAL OF MELATONIN FOR SLEEP DISTURBAN$0
M01 · FY2001 · RR
EXELON IN MILD TO SEVERE PROBABLE ALZHEIMER'S DISEASE IN COMMUNITY SETTING$0
M01 · FY2001 · RR
ALZHEIMERS DISEASE PREVENTION TRIAL WITH ESTROGENS$2,078,846
R01 · FY2000 · AG
CORE--EDUCATION AND INFORMATION TRANSFER$271,395
P50 · FY2000 · AG
CORE--MINORITY RECRUITMENT$228,404
U01 · FY2000 · AG
LY246708 TARTRATE VS PLACEBO IN MILD TO MODERATE ALZHEIMER'S DISEASE$121,168
M01 · FY2000 · RR
MULTICENTER TRIAL OF PREDNISONE IN ALZHEIMERS DISEASE$121,168
M01 · FY2000 · RR
ACETYL CARNITINE AS A TREATMENT FOR ALZHEIMERS DISEASE$121,168
M01 · FY2000 · RR
ALZHEIMER'S DISEASE PREVENTION TRIAL WITH ESTROGEN$0
M01 · FY2000 · RR
ALZHEIMER'S DISEASE PREVENTION TRIAL WITH ESTROGEN$0
M01 · FY2000 · RR
MULTICENTER PLACEBO CONTROLLED TRIAL OF MELATONIN FOR SLEEP DISTURBAN$0
M01 · FY2000 · RR
MULTICENTER PLACEBO CONTROLLED TRIAL OF MELATONIN FOR SLEEP DISTURBAN$0
M01 · FY2000 · RR
EXELON IN MILD TO SEVERE PROBABLE ALZHEIMER'S DISEASE IN COMMUNITY SETTING$0
M01 · FY2000 · RR
EXELON IN MILD TO SEVERE PROBABLE ALZHEIMER'S DISEASE IN COMMUNITY SETTING$0
M01 · FY2000 · RR
TRIAL OF 120,240,360 MG OF IDEBENONE IN PATIENTS WITH ALZHEIMER'S DISEASE$0
M01 · FY2000 · RR
TRIAL OF 120,240,360 MG OF IDEBENONE IN PATIENTS WITH ALZHEIMER'S DISEASE$0
M01 · FY2000 · RR
DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF DEPRENYL IN COMMUNITY ELDERLY$0
M01 · FY2000 · RR
DOUBLE BLIND PLACEBO CONTROLLED TRIAL OF DEPRENYL IN COMMUNITY ELDERLY$0
M01 · FY2000 · RR
VITAMIN E AND ARICEPT TO DELAY ALZHEIMER'S DISEASE$0
M01 · FY2000 · RR
VITAMIN E AND ARICEPT TO DELAY ALZHEIMER'S DISEASE$0
M01 · FY2000 · RR